We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manhattan Pharmaceuticals has acquired Tarpan Therapeutics, a privately held,
New York-based pharmaceutical company, in an all stock transaction that resulted
in Tarpan shareholders owning approximately 20% of the shares of Manhattan on
a fully-diluted basis.
Drugmaker aaipharma said on Monday it is highly likely
that it will seek Chapter 11 bankruptcy protection, after failing to make interest
payments on some corporate debt on April 1.
Describing the current treatments for systemic lupus erythematosus (SLE) as
inadequate, a new FDA document aims to help industry develop new treatments
for the immune system disease.
The pharmaceutical supply chain involves multiple organizations playing sometimes
overlapping roles in product distribution and contracting, but drugmakers clearly
have the most influence in establishing prices, according to a new report that
explains the multistep path a drug takes from manufacturer to patient.
The safety and efficacy of Chiron's immunosuppressant candidate Pulminiq will
be reviewed by the FDA's Pulmonary-Allergy Drugs Advisory Committee in a June
meeting.
Widespread use of electronic data capture (EDC) technology is helping Novartis
Pharmaceuticals cut down on errors during the clinical trial process and achieve
research savings approaching $100 million annually.
New research from Health Direction, the healthcare business intelligence specialists,
has today revealed that over half (52 percent) of (UK) NHS professionals surveyed
believe that integration and communication between different areas of the NHS
is the most important factor affecting their ability to carry out their role.
Progenics Pharmaceuticals, Inc. announced the pricing of an underwritten public
offering of 2 million shares of its common stock pursuant to an effective shelf
registration statement.